FDA Approves Second Waterless Solution for Dry Eye Disease
The new water-free cyclosporine-based solution is intended to treat the signs and symptoms of dry eye disease.
Source: medscape.com
Stay updated with breaking news from Linical Studi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new water-free cyclosporine-based solution is intended to treat the signs and symptoms of dry eye disease.
Many US clinicians who treat for multiple sclerosis adjusted drug regimens during the pandemic's early months to lower risk for COVID-19 infection -- but they didn't need to, experts say.